Eli Lilly's popular diabetes drug Mounjaro to face continued supply squeeze through April, FDA says

Amid steadily increasing demand for Eli Lilly’s popular diabetes med Mounjaro, it appears patients on multiple dose strengths may have to wait even longer than anticipated to re-up on supply.